Anlotinib Recruiting Phase 2 Trials for Extensive-Stage Small Cell Lung Cancer Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03841136Anlotinib Combined With Etoposide and Platinum in the Treatment of Lung Cancer